dsm-firmenich has divested its Animal Nutrition & Health business to CVC for approximately €2.2 billion, retaining a 20% equity stake to maintain involvement in the sector while focusing on its core consumer health and beauty operations.

Information on the target

dsm-firmenich, a leader in nutrition, health, and beauty, has announced the divestment of its Animal Nutrition & Health (ANH) business to CVC, a prominent global private markets manager. The transaction is valued at approximately €2.2 billion, which includes an earnout of up to €0.5 billion. Following the divestment, dsm-firmenich will retain a 20% equity stake in the ANH Companies, ensuring continued involvement in this vital sector.

The ANH business is recognized as a global provider of science-based animal nutrition and health solutions, offering a diverse range of products that enhance animal health, performance, and sustainability in livestock production. With annualized net sales of around €3.5 billion and a workforce of approximately 8,000 employees, the divestment encompasses all ANH activities, including Performance Solutions, Premix, and Precision Services, as well as Vitamins, Carotenoids, and Aroma Ingredients.

Industry overview in the target’s specific country

The animal nutrition and health industry is experiencing significant growth, driven by increasing global demand for high-quality animal protein and sustainable farming practices. In Switzerland, where dsm-firmenich is headquartered, t